Sharemaestro Newsreel

Atlassian and Doximity Just Surged 30% After Earnings: 3 Software Stocks with the Same Setup

It's a great feeling when a stock you own absolutely skyrockets higher after reporting earnings. Two software-as-a-service (SaaS) stocks, Atlassian (NASDAQ: TEAM) and Doximity (NYSE: DOCS), gave their investors something to cheer about when both companies' share prices skyrocketed more than 30% this past …

DarioHealth Corp. Q2 2026 Earnings Call Summary

DarioHealth Corp. Q2 2026 Earnings Call Summary - Moby Strategic Evolution and Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. …

Hims & Hers Stock Plunges Post Q2 Earnings Miss, Gross Margin Down

Hims & Hers Health, Inc. HIMS reported quarterly adjusted loss per share of 10 cents in second-quarter 2026, against the year-ago period's adjusted earnings per share (EPS) of 17 cents. The metric was wider than the Zacks Consensus Estimate of loss per share of …

SOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript

Tempus Q2 Earnings Call Highlights Data Growth and Pricing Upside

GDRX Q2 Deep Dive: Pharma Direct and Subscription Growth Drive Upgraded Outlook

Healthcare tech company GoodRx (NASDAQ:GDRX) reported Q2 CY2026 results beating Wall Street's revenue expectations , but sales fell by 1.3% year on year to $200.4 million. The company's full-year revenue guidance of $797.5 million at the midpoint came in 2.8% above analysts' estimates. Its …

Waystar Holding (WAY) Is Up 9.0% After Raising 2026 Outlook And Naming New CFO

Waystar Holding (WAY) saw its stock rise 9.0% after reporting strong Q2 2026 results, increasing its full-year 2026 revenue guidance to US$1.276 billion–US$1.294 billion, and completing a US$12.68 million share buyback. The company also announced Alpana Wegner as its new CFO, a move expected …

DarioHealth Q2 Earnings Call Highlights

Key Points Interested in DarioHealth Corp.? Here are five stocks we like better. Q2 revenue fell to $5.2 million as DarioHealth continued moving away from pharmaceutical services toward recurring B2B2C revenue, but gross margin improved to 62% and net loss narrowed to $7.9 million. …

Earnings call transcript: DarioHealth tops q2 2026 EPS forecast, misses revenue

DarioHealth (DRIO) reported a narrower-than-expected loss in Q2 2026, beating EPS forecasts by 32% with adjusted earnings of negative $0.85 per share, but missed revenue estimates at $5.18 million. The company's stock rose 4.93% after the announcement, driven by improved gross margins (62%) and …

Boeing upgraded, Under Armour downgraded: Wall Street's top analyst calls

Boeing upgraded, Under Armour downgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 …

Omada Health Touts Record Q2 as GLP-1 Demand Fuels Growth Strategy

Key Points Interested in Omada Health, Inc.? Here are five stocks we like better. Omada Health reported record second-quarter results, with revenue rising 43% year over year to $88 million, gross margin reaching 74% and adjusted EBITDA totaling $10.8 million. The company is broadening …

Hims & Hers Health Earnings: What To Look For From HIMS

Hims & Hers Health Earnings: What To Look For From HIMS Telehealth company Hims & Hers Health (NYSE:HIMS) will be announcing earnings results this Monday after market hours. Here's what to expect. Hims & Hers Health missed analysts' revenue expectations last quarter, reporting revenues …

Humana Healthy Horizons in Indiana Collaborates with HealthStream to Expand and Strengthen Home Care Workforce

Certification Scholarships and Innovative Retention Program Address Critical Health Need INDIANAPOLIS, August 11, 2026--(BUSINESS WIRE)--Humana Healthy Horizons in Indiana, Humana's Medicaid managed care plan, is collaborating with HealthStream (Nasdaq: HSTM), a leading healthcare technology platform company for clinical workforce solutions, to improve the lives …

Veeva Vault CRM Selected by Eli Lilly and Company

PLEASANTON, Calif., Aug. 11, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Eli Lilly and Company (Lilly) has committed to Veeva Vault CRM globally.Veeva Vault CRM Selected by Eli Lilly and Company Vault CRM is part of the Vault CRM Suite of …

Bronstein, Gewirtz & Grossman, LLC Is Investigating Phreesia, Inc. (PHR) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. (NYSE: PHR) securities who bought prior to March 30, 2026, and still hold their shares. The investigation focuses on whether Phreesia and its officers/directors engaged in corporate wrongdoing. …

3 Stocks Including Omada Health That May Be Priced Below Estimated Intrinsic Value

The article identifies three U.S. stocks—Omada Health (OMDA), LandBridge (LB), and On Holding (ONON)—that appear undervalued based on discounted cash flow analysis, despite a robust market. These companies exhibit strong expected earnings growth, though some, like Omada Health and LandBridge, have considerations such as …

DarioHealth Corp. 2Q 2026: Revenue $5.18M, Net loss $7.92M — 10-Q Summary

DarioHealth Corp. reported a Q2 2026 revenue of $5.18 million, a slight decrease from the previous year, but significantly improved its net loss to $7.92 million from $18.56 million in Q2 2025. The company saw a shift towards B2B revenue, now comprising 75% of …

DarioHealth Reports Second Quarter 2026 Financial Results

DarioHealth Corp. announced its second-quarter 2026 financial results, reporting $5.2 million in revenue, a gross margin increase to 62%, and a 30% year-over-year decrease in operating loss. The company highlighted strategic decisions to discontinue certain pharmaceutical-related businesses, successful expansion within existing customer relationships, and …

Veeva (VEEV) Stock Looks Strong On Cash Flow While Earnings Look Rich

Doximity Stock Surges in Overnight Trading as Chief Executive Highlights High-Margin AI Tool

Sei Investments Co. Has $1.63 Million Position in Heartflow, Inc. $HTFL

Sei Investments Co. significantly increased its stake in Heartflow, Inc. ($HTFL) by 342.5% in the first quarter, now owning 67,048 shares valued at $1.63 million. Other institutional investors also adjusted their positions in the company. Heartflow has received a "Moderate Buy" consensus rating from …

CoreWeave’s Forecast Is Key to Stopping Another Earnings Selloff

(Bloomberg) -- CoreWeave Inc. shares have been on a roll lately after a monthslong slump. Now, the neocloud provider's earnings after the close Tuesday can give investors a sense of whether the rally is sustainable. Most Read from Bloomberg China Unleashes $28 Trillion Capital …

Renaissance Technologies LLC Purchases 161,500 Shares of Simulations Plus, Inc. $SLP

Renaissance Technologies LLC significantly increased its stake in Simulations Plus, Inc. (NASDAQ:SLP) by purchasing 161,500 additional shares, bringing their total to 181,500 shares valued at $2.15 million. This move comes despite a cautious analyst sentiment, with several firms downgrading the stock to "Hold" or …

DOCS Q2 Deep Dive: AI Product Adoption Fuels Revenue Growth, Margins Face Investment Pressures

DOCS Q2 Deep Dive: AI Product Adoption Fuels Revenue Growth, Margins Face Investment Pressures Medical professional network Doximity (NYSE:DOCS) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 7.3% year on year to $156.6 million. The company expects next quarter's …

HealthEquity (NASDAQ:HQY) Hits New 52-Week High - Here's What Happened

HealthEquity (NASDAQ:HQY) recently reached a new 52-week high, trading up to $107.62, following a strong earnings report where adjusted EPS of $1.24 beat estimates by $0.13, and revenue increased 7.2% year-over-year. Analysts maintain a "Moderate Buy" rating with an average price target of $110.93, …

10x Genomics (TXG): Doubled, Then Doubled Again

10x Genomics (TXG) has been a significant winner for Hedgeye, with its stock price soaring over 157% since May 19 due to strong Signal Strength, favorable macroeconomic "Quads," and robust fundamental performance. The company recently reported strong second-quarter results, raised full-year guidance, and despite …

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teladoc Health, Inc. (TDOC) and Encourages Investors to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Teladoc Health, Inc. (TDOC) following the company's Q2 2026 financial results, which reported lower-than-expected revenue and a reduced full-year guidance. The investigation focuses on potential claims for purchasers of Teladoc Health securities, especially after …

PHR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce

Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Phreesia, Inc. (NYSE:PHR) and its officers. The lawsuit, filed on behalf of investors who purchased Phreesia securities between May 8, 2025, and March 30, 2026, alleges that the company made materially false …

Toast Stock And Two Founder Led Tech Names Backed By Strong Growth

This article highlights three founder-led tech companies—Toast (TOST), DLocal (DLO), and Hinge Health (HNGE)—known for their strong growth and management with "skin in the game." It discusses how their business models, financial performance, and market positions offer potential advantages, especially when traditional investments like …

Is Schrödinger (SDGR) Undervalued Following Its Profit Turn And Bristol Myers Squibb Deal?

Understanding the Setup: (HSTM) and Scalable Risk

This article provides an AI-driven analysis of Healthstream Inc. (NASDAQ: HSTM), identifying neutral near-term sentiment with a potential stalling of strong mid-term sentiment. It outlines institutional trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis, emphasizing risk management …

Definitive Healthcare targets $220M-$222M 2026 revenue while planning Turbo general availability before year-end

Earnings Call Insights: Definitive Healthcare (DH) Q2 2026 MANAGEMENT VIEW * "Total revenue was $55.2 million, down 9% year-over-year. Adjusted EBITDA was $14.6 million, representing a margin of 26%" (CEO Kevin Coop). * "Our diversified and provider businesses continue to be further along in …

HealthEquity, Inc. (HQY) Stock Analysis: Investor Optimism With 13% Upside Potential

HealthEquity, Inc. (HQY) is attracting investor attention with its robust service offerings in health information services, specializing in HSAs, FSAs, and other health-related financial services. Currently trading near its 52-week high at $104.63, analysts project a 13.29% upside potential with a consensus target price …

Jurgi Camblong Sells 8,500 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock

Evolent Health, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:EVH) 2026-08-10

Heartflow (HTFL) CMO has 2,272 shares withheld to cover RSU tax

Heartflow, Inc.'s Chief Medical Officer, Campbell Rogers, reported two Code F transactions where a total of 2,272 shares of Common Stock were withheld by the issuer on August 6-7, 2026. This action was taken to satisfy income tax withholding obligations related to the vesting …